Oncology nurses are familiar with the concept of financial toxicity, which refers to the significant financial burden cancer ...

AUTX-703, a novel, oral KAT2A/B degrader, has received fast track designation for use in relapsed/refractory AML.

Experts discuss the role of supportive therapies, such as antiemetics, nutritional support, and physical activity, in improving outcomes and patient comfort during treatment.

Panelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease ...

Panelists discuss how their lived experiences and insights as patients should inform research priorities, treatment development, and care delivery improvements while sharing hopes for a future cure ...

Panelists discuss how they maintain treatment adherence through digital health apps, calendar reminders, and symptom journals while working closely with their care teams to address uncertainties and ...

Panelists discuss how they navigated initial treatment confusion by seeking clarification from healthcare providers, consulting patient resources, and connecting with support groups to better ...

Axel Stuart Merseburger, MD, PhD, explained that with TKIs like axitinib, it is necessary for oncology nurses to spend time ...

Avelumab in combination with axitinib was found effective and safe as frontline treatment for advanced RCC in real-world ...

Tivozanib Combo Yields Similar PROs to Monotherapy in Advanced Clear Cell RCC ...